FDA 483 - Shawn K. Hassler, M.D. - October 27, 2022

An FDA inspection of Shawn K. Hassler, M.D., a clinical investigator in San Francisco, CA, revealed a significant deviation from the investigational plan. The firm failed to ensure that multiple subjects met the protocol's required medication history eligibility criteria. This indicates a failure to conduct the investigation in accordance with the established plan.